Discover the complete list of Active Pharmaceutical Ingredients (APIs) manufactured or distributed by Genzyme Corp. View detailed product information, certifications, and sourcing options for each API. Connect with Genzyme Corp for compliant, high-quality pharmaceutical ingredients trusted by global clients.
Country: U.S.A.
Supplier Description: Genzyme Corp. was a pioneering U.S. biotechnology company founded in 1981 and headquartered in Cambridge, Massachusetts. It became widely recognized for discovering, developing, and manufacturing groundbreaking therapies for rare genetic diseases, including enzyme replacement treatments such as Cerezyme® for Gaucher disease and Fabrazyme® for Fabry disease, which were manufactured to address previously unmet medical needs. Genzyme also developed treatments for other serious conditions across renal, immune, and metabolic disorders In 2011, the company was acquired by French pharmaceutical giant Sanofi for approximately $20.1 billion and operated as a fully owned subsidiary under the Sanofi Genzyme business unit, maintaining a global presence in research, development, and manufacturing of specialty therapies. Over time, Genzyme’s heritage and product portfolio were fully integrated into the broader Sanofi brand, continuing its focus on rare diseases, multiple sclerosis, oncology, and immunology with products that are developed and manufactured in regulated facilities worldwide - Show More
